Zum Inhalt springen
Home » Pliant Therapeutics Announces Appointment of Steve Krognes to Board of Directors

Pliant Therapeutics Announces Appointment of Steve Krognes to Board of Directors

Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today announced the appointment of Steve Krognes to its Board of Directors.

Pliant Therapeutics Announces Appointment of Steve Krognes to Board of Directors